HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Long-term results of the treatment of diffuse systemic scleroderma with interferon-gamma].

Abstract
There are very few drugs effective in the treatment of diffuse scleroderma and therefore we conducted an open study with gamma interferon. Among 20 diffuse scleroderma, evolving since less than 3 years, an improvement was observed in 8 patients. There was no serious side effect. Survival of these 20 patients was 85% at 5 years.
AuthorsO Blétry, R Laraki, J Cabane, C Francès, J C Piette, M Soubrier, B Wechsler, C de Gennes, C Valat, J Cosserat
JournalLa Revue de medecine interne (Rev Med Interne) Vol. 14 Issue 10 Pg. 978 ( 1993) ISSN: 0248-8663 [Print] France
Vernacular TitleRésultats à long terme du traitement des sclérodermies systémiques diffuses par l'interféron gamma.
PMID8009071 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Interferon-gamma
Topics
  • Adult
  • Aged
  • Drug Evaluation
  • Female
  • Humans
  • Interferon-gamma (therapeutic use)
  • Male
  • Middle Aged
  • Scleroderma, Systemic (therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: